PEGylated Recombinant Factor VIII
PEGylated Recombinant Factor VIII Uses, Dosage, Side Effects, Food Interaction and all others data.
PEGylated Recombinant Factor VIII is under investigation in clinical trial NCT02585960 (BAX 855 Pk-guided Dosing).
| Trade Name | PEGylated Recombinant Factor VIII |
| Generic | PEGylated Recombinant Factor VIII |
| PEGylated Recombinant Factor VIII Other Names | Adynovate, Adynovi, Antihemophilic factor (recombinant), pegylated (20 kda), Antihemophilic factor (recombinant), pegylated (mw 20000), Antihemophilic factor, pegylated (mw 20000) human sequence recombinant, PEGylated Recombinant Factor VIII, Pegylated rfviii |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PEGylated Recombinant Factor VIII
